BioAtla, Inc. (BCAB)

NASDAQ: BCAB · IEX Real-Time Price · USD
3.74
-0.20 (-5.08%)
Aug 8, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018
Revenue
0.250.435.210.63
Revenue Growth (YoY)
-41.73%-91.75%-51.07%-
Gross Profit
0.250.435.210.63
Selling, General & Admin
38.4210.67.5512.56
Research & Development
58.2719.9325.9226.31
Operating Expenses
96.6930.5333.4738.86
Operating Income
-96.44-30.1-28.27-28.23
Interest Expense / Income
01.391.630.95
Other Expense / Income
-1.044.37-0.1-0.2
Pretax Income
-95.4-35.85-29.79-28.98
Net Income
-95.4-35.85-29.79-28.98
Net Income Common
-95.4-35.85-29.79-28.98
Shares Outstanding (Basic)
3585555
Shares Outstanding (Diluted)
3585555
Shares Change
310.07%-84.56%--
EPS (Basic)
-2.76-3.19-0.53-0.52
EPS (Diluted)
-2.76-3.19-0.53-0.52
Free Cash Flow Per Share
-1.83-4.38-0.20-0.67
Gross Margin
100.00%100.00%100.00%100.00%
Operating Margin
-38576.00%-7016.08%-543.62%-265.68%
Profit Margin
-38160.80%-8357.34%-572.96%-272.69%
Free Cash Flow Margin
-25255.20%-8606.99%-214.50%-341.63%
EBITDA
-94.07-33.46-27.3-27.24
EBITDA Margin
-37627.60%-7798.60%-525.08%-256.29%
Depreciation & Amortization
1.331.010.860.79
EBIT
-95.4-34.46-28.16-28.03
EBIT Margin
-38159.60%-8033.57%-541.62%-263.76%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).